ZA957414B - Oxazoloquinolinone derivatives their preparation and their therapeutic application - Google Patents
Oxazoloquinolinone derivatives their preparation and their therapeutic applicationInfo
- Publication number
- ZA957414B ZA957414B ZA957414A ZA957414A ZA957414B ZA 957414 B ZA957414 B ZA 957414B ZA 957414 A ZA957414 A ZA 957414A ZA 957414 A ZA957414 A ZA 957414A ZA 957414 B ZA957414 B ZA 957414B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- therapeutic application
- oxazoloquinolinone
- derivatives
- oxazoloquinolinone derivatives
- Prior art date
Links
- ADUUMUIYOPOCGI-UHFFFAOYSA-N 3h-[1,3]oxazolo[4,5-h]quinolin-2-one Chemical class C1=CC=NC2=C(OC(=O)N3)C3=CC=C21 ADUUMUIYOPOCGI-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- IYFPFSMWFRSRCD-UHFFFAOYSA-N 3,3a,4,5-tetrahydro-[1,3]oxazolo[3,4-a]quinolin-1-one Chemical compound C1=CC=C2N3C(=O)OCC3CCC2=C1 IYFPFSMWFRSRCD-UHFFFAOYSA-N 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9410600A FR2724171B1 (fr) | 1994-09-05 | 1994-09-05 | Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA957414B true ZA957414B (en) | 1996-04-15 |
Family
ID=9466686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA957414A ZA957414B (en) | 1994-09-05 | 1995-09-04 | Oxazoloquinolinone derivatives their preparation and their therapeutic application |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5641785A (cs) |
| EP (1) | EP0699680B1 (cs) |
| JP (1) | JP4225585B2 (cs) |
| KR (1) | KR100392523B1 (cs) |
| CN (1) | CN1055472C (cs) |
| AT (1) | ATE190311T1 (cs) |
| AU (1) | AU687591B2 (cs) |
| CA (1) | CA2157427C (cs) |
| CZ (1) | CZ286128B6 (cs) |
| DE (1) | DE69515402T2 (cs) |
| DK (1) | DK0699680T3 (cs) |
| ES (1) | ES2145886T3 (cs) |
| FI (1) | FI110945B (cs) |
| FR (1) | FR2724171B1 (cs) |
| GR (1) | GR3033554T3 (cs) |
| HU (1) | HU218587B (cs) |
| IL (1) | IL115276A (cs) |
| NO (1) | NO306617B1 (cs) |
| NZ (1) | NZ272920A (cs) |
| PL (1) | PL184412B1 (cs) |
| PT (1) | PT699680E (cs) |
| RU (1) | RU2141482C1 (cs) |
| SI (1) | SI0699680T1 (cs) |
| SK (1) | SK281867B6 (cs) |
| TW (1) | TW356467B (cs) |
| UA (1) | UA41916C2 (cs) |
| ZA (1) | ZA957414B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1078632A1 (en) * | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| WO2005090309A1 (en) * | 2004-03-12 | 2005-09-29 | Wyeth | 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection |
| MY147757A (en) * | 2007-03-09 | 2013-01-15 | Sanofi Aventis | Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
| RU2366430C2 (ru) | 2007-05-23 | 2009-09-10 | Виктор Иванович Рощин | Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция |
| AR078171A1 (es) | 2009-09-15 | 2011-10-19 | Sanofi Aventis | Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas |
| CN105949120B (zh) | 2016-05-27 | 2018-07-24 | 广东工业大学 | 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0128120A3 (de) * | 1983-06-02 | 1985-11-13 | Ciba-Geigy Ag | Trisubstituierte Oxazolidinone |
| FR2624861B1 (fr) * | 1987-12-21 | 1990-06-01 | Delalande Sa | Carbamates tricycliques, leur procede de preparation et leur application en therapeutique |
| ES2013391A6 (es) * | 1989-02-08 | 1990-05-01 | Consejo Superior Investigacion | Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles. |
| JPH04295470A (ja) * | 1991-03-22 | 1992-10-20 | Wakamoto Pharmaceut Co Ltd | モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法 |
-
1994
- 1994-09-05 FR FR9410600A patent/FR2724171B1/fr not_active Expired - Lifetime
-
1995
- 1995-09-01 CA CA2157427A patent/CA2157427C/en not_active Expired - Lifetime
- 1995-09-01 DE DE69515402T patent/DE69515402T2/de not_active Expired - Lifetime
- 1995-09-01 EP EP95401989A patent/EP0699680B1/fr not_active Expired - Lifetime
- 1995-09-01 PT PT95401989T patent/PT699680E/pt unknown
- 1995-09-01 ES ES95401989T patent/ES2145886T3/es not_active Expired - Lifetime
- 1995-09-01 SI SI9530413T patent/SI0699680T1/xx unknown
- 1995-09-01 US US08/523,508 patent/US5641785A/en not_active Expired - Lifetime
- 1995-09-01 DK DK95401989T patent/DK0699680T3/da active
- 1995-09-01 AT AT95401989T patent/ATE190311T1/de active
- 1995-09-02 TW TW084109192A patent/TW356467B/zh not_active IP Right Cessation
- 1995-09-04 CN CN95117143A patent/CN1055472C/zh not_active Expired - Lifetime
- 1995-09-04 NO NO953458A patent/NO306617B1/no not_active IP Right Cessation
- 1995-09-04 UA UA95094019A patent/UA41916C2/uk unknown
- 1995-09-04 SK SK1089-95A patent/SK281867B6/sk not_active IP Right Cessation
- 1995-09-04 PL PL95310273A patent/PL184412B1/pl unknown
- 1995-09-04 RU RU95114741A patent/RU2141482C1/ru active
- 1995-09-04 FI FI954141A patent/FI110945B/fi not_active IP Right Cessation
- 1995-09-04 ZA ZA957414A patent/ZA957414B/xx unknown
- 1995-09-04 HU HU9502578A patent/HU218587B/hu unknown
- 1995-09-04 JP JP22646295A patent/JP4225585B2/ja not_active Expired - Lifetime
- 1995-09-04 AU AU30415/95A patent/AU687591B2/en not_active Expired
- 1995-09-04 KR KR1019950028714A patent/KR100392523B1/ko not_active Expired - Lifetime
- 1995-09-04 NZ NZ272920A patent/NZ272920A/en not_active IP Right Cessation
- 1995-09-04 CZ CZ19952262A patent/CZ286128B6/cs not_active IP Right Cessation
- 1995-09-12 IL IL11527695A patent/IL115276A/en not_active IP Right Cessation
-
2000
- 2000-05-31 GR GR20000401246T patent/GR3033554T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9103784A (pt) | Composicao de tratamento de cabelo | |
| HU9702040D0 (en) | Atherosclerosis treatment | |
| FI930977A0 (fi) | Taxanderivat, deras framstaellning och onkologiska anvaendning | |
| ATE126221T1 (de) | Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. | |
| ATE160148T1 (de) | Sonnenfilter, diese enthaltende kosmetische lichtschutzzusammensetzungen sowie deren verwendung | |
| IL115276A0 (en) | Oxazoloquinolinone derivatives their preparation and their therapeutic application | |
| CA2251003A1 (fr) | Nouveaux composes derives de n-aryl 2-hydroxy alkylamides | |
| GR3026656T3 (en) | Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses | |
| AU4585096A (en) | New tricyclic derivatives, their preparation, their use for the preparation of optically active or racemic colchicine and thiocolchicine and analogues or derivatives and intermediates | |
| DE69033342D1 (de) | Etoposidanaloge | |
| HU9402119D0 (en) | Alkyl derivatives of trazodone | |
| FR2716198B1 (fr) | Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification. | |
| FI952203A0 (fi) | Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi | |
| ATE153340T1 (de) | Cyathane derivate und diese enthaltende nervenwachstumsfaktor produktion stimulatoren und antimikrobielle mittel | |
| FI912269A0 (fi) | 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa. | |
| AU1599192A (en) | Hair treatment composition | |
| NO994107L (no) | Preparater for behandling eller forhindring av prostatakreft | |
| DE3865521D1 (de) | 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe. | |
| GB9520092D0 (en) | Chemical compounds | |
| UA19097A (uk) | D-1-ФЕHІЛ-2-МЕТИЛАМІHОПРОПАHОЛА 1-5,6,7-ТРИОКСИФЛАВОH-7-0-beta-D-ГЛЮКУРОHИДАТ, ЩО МАЄ ОКИСЛЮВАЛЬHУ ДІЮ ТА РОЗШИРЮЄ СУДИHИ | |
| IT1245737B (it) | Trialchilsilil tetrafluoroetanfosfonati e procedimento per la loro preparazione | |
| SE8600411D0 (sv) | Isokinolinderivat, deras framstellning och anvendning |